Ambry Genetics

Konica Minolta establishing itself as precision medicine player with $1B Ambry Genetics deal

Konica views the deal as a "stepping stone" marking its debut as a player in the space and plans to bring Ambry’s products to Japan and then to Europe.

By Stephanie Baum and Juliet Preston

Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.

By FASENRA, Sponsored Content

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News

Artificial Intelligence

Why Your Patients Are Leaving and How to Stop It

Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.

By Bryan Sequeira, Director, Product Management Greenway Health